11 drug(s) with this reaction
5,306 total reports
Renal Failure has been reported as an adverse reaction across 11 drug(s) manufactured by Haleon Us Holdings Llc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 5,306 adverse event reports mention renal failure in connection with Haleon Us Holdings Llc products.
This page provides a breakdown of which Haleon Us Holdings Llc drugs are most commonly associated with renal failure, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Haleon Us Holdings Llc drugs have renal failure listed in their FDA adverse event reports, sorted by report count:
In addition to renal failure, the following adverse reactions have been reported across Haleon Us Holdings Llc's drug portfolio:
11 drug(s) manufactured by Haleon Us Holdings Llc have renal failure listed in their FDA adverse event reports: CALCIUM CARBONATE, FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE, ACETAMINOPHEN, ASPIRIN, AND CAFFEINE, and others.
There are a combined 5,306 reports of renal failure across 11 Haleon Us Holdings Llc drug(s) in the FDA adverse event database.